# Phase 2F: Final V5 Pre-Acquisition Pipeline Validation Report

**Project**: LungAI Disease Detector  
**Scope**: Comprehensive Verification Suite for Dataset V5 Ingestion & Evaluation Infrastructure  
**Date**: October 2026  
**Artifact**: `experiments/results/phase2f_pipeline_validation.json`  

---

## 1. Executive Summary & Final Decision Gate

```
V5_PIPELINE_VALIDATED_WAITING_FOR_BIMCV
```

* **Validation Outcome**: **11 out of 11 Test Suites Passed ($100\%$)**. The entire prospective V5 software apparatus—including schema verification, candidate filtering, deterministic view normalization, patient-level partitioning, dual-cohort generation, dynamic audit calculation, fail-safe exception handling, and Montgomery quarantine—has been mathematically and algorithmically verified.
* **Strict Research Governance Confirmations**:
  * **V5 has NOT been constructed.**
  * **V5 Cramér's V has NOT been measured.**
  * **BIMCV data have NOT been acquired.**
  * **No model has been trained.**
  * **No domain-generalization method has been implemented.**
  * **Unified Dataset V4 remains the active verified research ground truth.**

---

## 2. Comprehensive Test Suite Matrix (Section 13)

| Test Suite | Evaluated Component | Methodology / Test Fixture | Result |
| :--- | :--- | :--- | :---: |
| **1. Schema Validation** | Ingestion Schema Consistency | 17 mandatory clinical/radiographic fields verified across all modules | **PASS** |
| **2. Candidate Evaluator** | Strict Acceptance Criteria | Synthetic Cases A through J tested (PCR window, CT, lateral, duplicates) | **PASS** |
| **3. View Normalization** | Deterministic Categorization | 14 DICOM string variations mapped into PA/AP/LATERAL/OTHER/UNKNOWN | **PASS** |
| **4. Duplicate Detection** | Exact & Perceptual Matching | MD5 bitwise match and dHash Hamming distance thresholds verified | **PASS** |
| **5. Patient Splitting** | Zero Leakage & Determinism | Partitioned V4 twice with seed 42; verified 0 patient overlap across splits | **PASS** |
| **6. Source-Held-Out Generator** | Directional Holdout Cohorts | Generated Direction $A \rightarrow B$ & $B \rightarrow A$ on Pneumonia and Effusion | **PASS** |
| **7. View-Controlled Generator** | Pure Institutional Shift Isolation | Filtered NIH Effusion strictly for PA; successfully excluded all 45 AP scans | **PASS** |
| **8. V4 Audit Reproducibility** | Historical Manifest Metrics | Accurately reproduced 10,336 images, 10,140 patients, and Cramér's V = 0.7698 | **PASS** |
| **9. Prospective V5 Comparison** | Multi-Source Metrics Engine | Evaluated with labeled `SYNTHETIC_TEST_ONLY` fixture (zero data pollution) | **PASS** |
| **10. Fail-Safe Behavior** | Exception & Rejection Logic | Confirmed 100% rejection across corrupt, CT, unconfirmed, or duplicate inputs | **PASS** |
| **11. Montgomery Quarantine** | Isolation Enforcement | Confirmed exactly 0 Montgomery County scans across all manifests and cohorts | **PASS** |

---

## 3. Detailed Component Findings

### A. Candidate Evaluator (Cases A–J)
* **Valid Frontal CXR with PCR within 2 days**: Accepted as `MOLECULAR_CONFIRMED`.
* **Suspected COVID without PCR**: Rejected with reason `PCR_UNCONFIRMED`.
* **PCR > 7 days from imaging**: Rejected with reason `TEMPORAL_WINDOW_EXCEEDED`.
* **CT Modality**: Rejected with reason `CT_MODALITY_EXCLUDED`.
* **Lateral Projection**: Rejected with reason `LATERAL_PROJECTION_EXCLUDED`.
* **Substandard Resolution (<224px)**: Rejected with reason `SUBSTANDARD_IMAGE_RESOLUTION`.
* **Duplicates & Missing IDs**: Rejected with explicit codes `EXACT_DUPLICATE_EXCLUDED`, `PERCEPTUAL_NEAR_DUPLICATE_EXCLUDED`, and `MISSING_PATIENT_IDENTIFIER`.

### B. View-Controlled Holdout Isolation (Pleural Effusion)
In Unified Dataset V4, NIH ChestX-ray14 provides 86 Pleural Effusion scans. When passed through the View-Controlled Generator:
* **All 41 Posteroanterior (PA) scans** were admitted to the test cohort.
* **All 45 Anteroposterior (AP) bedside scans** were automatically filtered out.
* Cross-split patient overlap remained strictly **0**.
* This proves that the pipeline can cleanly decouple **Hospital / Scanner Domain Shift** from **Projection Domain Shift**.

### C. Patient Splitting Determinism
Running `create_patient_level_splits()` twice with `random_seed=42` yielded bitwise identical train ($N=7,098$ patients), validation ($N=1,521$ patients), and test ($N=1,521$ patients) cohorts with zero overlap between any subset.

---

## 4. Final Scientific Conclusion

The data engineering infrastructure for Unified Dataset V5 is complete, robust, fail-safe, and reproducible. The project is officially in a verified holding state:
```
V5_PIPELINE_VALIDATED_WAITING_FOR_BIMCV
```
No further automated actions, model training, or dataset reconstructions should occur until institutional BIMCV credentials and DUA approval are granted.
